The University of Chicago Header Logo

Connection

Sean David to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Sean David has written about Combined Modality Therapy.
Sean David
Connection Strength
0.150
Combined Modality Therapy
  1. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction. 2013 Dec; 108(12):2202-11.
    View in: PubMed
    Score: 0.084
  2. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2021 11 30; 11:CD011823.
    View in: PubMed
    Score: 0.037
  3. [Smoking cessation]. Praxis (Bern 1994). 2008 Nov 05; 97(22):1185-6.
    View in: PubMed
    Score: 0.015
  4. A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. Nicotine Tob Res. 2008 Jan; 10(1):231-40.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.